Bioventus Inc. (BVS)
NASDAQ: BVS · IEX Real-Time Price · USD
6.38
-0.25 (-3.77%)
At close: May 17, 2024, 4:00 PM
6.65
+0.27 (4.23%)
After-hours: May 17, 2024, 6:43 PM EDT
Bioventus Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bioventus stock have an average target of 8.50, with a low estimate of 8.00 and a high estimate of 9.00. The average target predicts an increase of 33.23% from the current stock price of 6.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bioventus stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +25.39% | May 8, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +41.07% | Mar 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold → Strong Buy Upgrades $3.66 → $7 | Hold → Strong Buy | Upgrades | $3.66 → $7 | +9.72% | Dec 7, 2023 |
| Craig-Hallum | Craig-Hallum | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | -21.63% | Apr 3, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $13 → $2.5 | Hold | Maintains | $13 → $2.5 | -60.82% | Nov 30, 2022 |
Financial Forecast
Revenue This Year
533.31M
from 512.35M
Increased by 4.09%
Revenue Next Year
567.58M
from 533.31M
Increased by 6.43%
EPS This Year
0.16
from -2.49
EPS Next Year
0.38
from 0.16
Increased by 140.42%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 555.5M | 592.2M | 617.4M |
| Avg | 533.3M | 567.6M | 593.9M |
| Low | 517.0M | 547.8M | 576.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.4% | 11.0% | 8.8% |
| Avg | 4.1% | 6.4% | 4.6% |
| Low | 0.9% | 2.7% | 1.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.20 | 0.49 | 0.57 |
| Avg | 0.16 | 0.38 | 0.55 |
| Low | 0.12 | 0.25 | 0.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 211.9% | 49.0% |
| Avg | - | 140.4% | 43.4% |
| Low | - | 61.0% | 39.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.